Original Post Constituent Update May 9, 2022 Today, the U.S. Food and Drug Administration (FDA) posted warning letters to 11 companies for selling adulterated dietary supplements that contain, in some cases, new dietary ingredients (NDIs) for which the FDA has not received the required premarket NDI notifications and, in others, unsafe food additives. Some of…
Read MoreOriginal Post For Immediate Release: May 05, 2022 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and…
Read MoreOriginal Post The FDA is aware of counterfeit at-home over-the-counter (OTC) COVID-19 diagnostic tests being distributed or used in the United States. These counterfeit tests should not be used or distributed. Counterfeit COVID-19 tests are tests that are not authorized, cleared, or approved by the FDA for distribution or use in the United States, but are made to look…
Read MoreOriginal Post Do not use recalled Similac, Alimentum, or EleCare powdered infant formulas produced at Abbott Nutrition’s Sturgis, MI, facility If you want to check if your powdered formula is part of the recall, you can enter the product lot code on the bottom of your package on the company’s website. If you have questions or…
Read MoreOriginal Post For Immediate Release: April 25, 2022 Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, who are: Hospitalized, or Not…
Read MoreOriginal Post Company Announcement Date: April 22, 2022 FDA Publish Date: April 22, 2022 Product Type: Drugs Reason for Announcement: Due to N-Nitroso-Quinapril Content Company Name: Pfizer Brand Name: Pfizer Product Description: Accupril (Quinapril HCl) tablets 10mg, 20mg, 40 mg Company Announcement FOR IMMEDIATE RELEASE – NEW YORK, NY., April 22,2022. Pfizer is voluntarily recalling five…
Read MoreOriginal Post The drug overdose epidemic in the United States is a clear and present public health, public safety, and national security threat. DEA is committed to making communities safer and healthier, and we can do this by reducing overdoses and overdose deaths. Don’t let prescription drugs fall into the wrong hands. The message is simple:…
Read MoreOriginal Post Inappropriate interpretation of results may lead to potentially improper medical decisions For Immediate Release: April 19, 2022 Today, the U.S. Food and Drug Administration is warning the public of the risk of false results, inappropriate use and inappropriate interpretation of results with non-invasive prenatal screening (NIPS) tests, also called cell-free DNA tests or…
Read MoreOriginal Post Test provides results in less than three minutes For Immediate Release: April 14, 2022 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with a SARS-CoV-2 infection. The test can be performed in environments where…
Read MoreOriginal Post DEA is making communities safer and healthier by helping the public safely dispose of unneeded controlled substances to reduce opioid addiction WASHINGTON – The Drug Enforcement Administration will host its 22nd National Prescription Drug Take Back Day on Saturday, April 30 from 10 a.m. to 2 p.m. This bi-annual event offers free, anonymous disposal…
Read More